Pharmacy of Ambroise-Paré hospital, APHP
Boulogne-Billancourt, 92100, France
NCT Number: NCT05248490
The primary objective is to evaluate the impact of Pharmaceutical Interviews in the patient self-management of non-severe side effects caused by antibiotics prescribed for the treatment of osteoarticular infections when the patient returns home.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Boulogne-Billancourt, 92100, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Pharmaceutical interview with pharmacist: to be informed treatment taken and related SAE informations at the end of hospitalization
Time frame: at day 7
Phone call to evaluate the self-management of adverse effects. Self-management evaluation (optimal choice/non-optimal choice) performs thanks to the use of a standardized decision-tree.
Proportion of patients with an optimal or non-optimal self-management.
Time frame: at day 14
Phone call to evaluate the self-management of adverse effects. Self-management evaluation (optimal choice/non-optimal choice) performs thanks to the use of a standardized decision-tree.
Proportion of patients with an optimal or non-optimal self-management.
Time frame: at day 7
Questionnaire, 12 points:
Assistance Publique - Hôpitaux de Paris
Other
Acronym: EFIRAD
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04625478
Bone and Joint Infection, Staphylococcus
Lyon, France
View Trial DetailsNCT04563325
Arthritis, Arthritis, Infectious
Copenhagen, Denmark
View Trial DetailsNCT03009045
Bone Diseases, Bone Diseases, Infectious
Torrance, California, United States
View Trial DetailsNCT04373278
Bone and Joint Infection
Lyon, France
View Trial Details